Weaver Consulting Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$591K Sell
1,633
-117
-7% -$40.1K 0.12% 147
2026
Q1
$616K Sell
1,750
-49
-3% -$17.5K 0.15% 121
2025
Q4
$589K Buy
1,799
+103
+6% +$32.7K 0.14% 127
2025
Q3
$479K Buy
1,696
+4
+0.2% +$1.16K 0.12% 142
2025
Q2
$472K Buy
1,692
+16
+1% +$4.53K 0.13% 131
2025
Q1
$522K Buy
1,676
+35
+2% +$10.3K 0.16% 116
2024
Q4
$428K Sell
1,641
-5
-0.3% -$1.48K 0.13% 126
2024
Q3
$530K Hold
1,646
0.17% 107
2024
Q2
$514K Hold
1,646
0.18% 102
2024
Q1
$468K Sell
1,646
-100
-6% -$29.3K 0.17% 108
2023
Q4
$503K Sell
1,746
-35
-2% -$9.54K 0.2% 85
2023
Q3
$479K Buy
1,781
+100
+6% +$25K 0.22% 83
2023
Q2
$373K Hold
1,681
0.16% 111
2023
Q1
$406K Sell
1,681
-87
-5% -$21.4K 0.19% 106
2022
Q4
$464K Hold
1,768
0.24% 78
2022
Q3
$399K Hold
1,768
0.23% 89
2022
Q2
$430K Buy
1,768
+91
+5% +$22.3K 0.24% 82
2022
Q1
$406K Sell
1,677
-30
-2% -$6.89K 0.2% 101
2021
Q4
$384K Buy
1,707
+105
+7% +$22.2K 0.18% 102
2021
Q3
$341K Buy
1,602
+45
+3% +$10.4K 0.19% 101
2021
Q2
$380K Buy
1,557
+329
+27% +$80.9K 0.21% 94
2021
Q1
$306K Sell
1,228
-32
-3% -$7.63K 0.19% 99
2020
Q4
$290K Hold
1,260
0.18% 99
2020
Q3
$320K Hold
1,260
0.18% 82
2020
Q2
$297K Hold
1,260
0.17% 83
2020
Q1
$255K Hold
1,260
0.17% 80
2019
Q4
$244K Hold
1,260
0.13% 98
2019
Q3
$222K Sell
1,260
-100
-7% -$19.2K 0.12% 95
2019
Q2
$251K Hold
1,360
0.14% 87
2019
Q1
$239K Buy
+1,360
New +$260K 0.07% 194

Other funds holding AMGN

Weaver Consulting Group's AMGN Position: Q2 2026 in Review

Weaver Consulting Group reduced its Amgen (AMGN) stake by 6.7% in Q2 2026, selling an estimated $40.1K and leaving 1,633 shares worth $591K. The position accounts for 0.12% of the portfolio, ranked #147.

Weaver Consulting Group first reported a position in AMGN in Q1 2019 and has held it in 30 quarters since. The position peaked at $616K in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Weaver Consulting Group held 1,633 shares of Amgen worth $591K as of Q2 2026.
  • Weaver Consulting Group sold 117 Amgen shares in Q2 2026, an estimated $40.1K.
  • Amgen made up 0.12% of Weaver Consulting Group's portfolio in Q2 2026, its #147 holding.
  • Weaver Consulting Group first reported a position in Amgen in Q1 2019 and has held it in 30 quarters since.
  • Weaver Consulting Group's Amgen position peaked at $616K in Q1 2026.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Weaver Consulting Group's 13F filing for Q2 2026, filed 29 Jul 2026.